Immodulon Therapeutics

    OverviewSuggest Edit

    Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer. Its drug candidate IMM-101 is applicable to a range of cancers. The company provides treatments for advanced melanoma, skin cancer, and for advanced pancreatic cancer.
    TypePrivate
    Websiteimmodulon.com

    Latest Updates

    Employees (est.) (Mar 2020)10

    Immodulon Therapeutics Online and Social Media Presence

    Embed Graph

    Immodulon Therapeutics Frequently Asked Questions

    • How many employees does Immodulon Therapeutics have?

      Immodulon Therapeutics has 10 employees.

    • Who are Immodulon Therapeutics competitors?

      Competitors of Immodulon Therapeutics include Mirati Therapeutics, Clovis Oncology and CytomX Therapeutics.